花旗发表报告,指上周五(11日)泰格医药(03347.HK) 公布中证监对泰格医药联合创始人叶小平及曹晓春的调查结果,其中浙江监管局拟对叶、曹二人分别处以警告及各罚款50万元人民币。该调查涉及彼等于公司持股变动中涉嫌违反信息披露义务。结果与花旗先前之估计一致,并消除监管不确定性。花旗对泰格医药的订单增长及盈利可见度维持正面;重申“买入”评级及首选股地位,泰格(300347.SZ) A股目标价67元...
Source Link花旗发表报告,指上周五(11日)泰格医药(03347.HK) 公布中证监对泰格医药联合创始人叶小平及曹晓春的调查结果,其中浙江监管局拟对叶、曹二人分别处以警告及各罚款50万元人民币。该调查涉及彼等于公司持股变动中涉嫌违反信息披露义务。结果与花旗先前之估计一致,并消除监管不确定性。花旗对泰格医药的订单增长及盈利可见度维持正面;重申“买入”评级及首选股地位,泰格(300347.SZ) A股目标价67元...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.